The FDA announced accelerated approval of sevabertinib (Hyrnuo) for HER2-positive non-small cell lung cancer (NSCLC).
Amgen's Imdelltra received full approval from the Food and Drug Administration for use in patients with lung cancer. The biotechnology company said Wednesday Imdelltra received approval for adult ...
Targeted therapies, guided by molecular testing, offer significant benefits, including fewer side effects and personalization ...
At the recent CURE Educated Patient® Lung Cancer Summit, held in tandem with the 2025 PER® New York Lung Cancer Symposium, Dr ...
Treatment innovations in advanced lung cancer and melanoma over the past 2 decades have significantly improved OS, but they ...
Living with lung cancer often means spending more time in waiting rooms than in the moments that matter, but a new South ...
Scientists used CRISPR to disable the NRF2 gene, restoring chemotherapy sensitivity in lung cancer cells and slowing tumor ...
Lung cancer is the leading cause of cancer-related deaths in the United States. As we start Lung Cancer Awareness Month, a ...
The latest national report of the American Lung Association 2025: State of Lung Cancer Report was published on Nov 5, 2025, ...
New artificial intelligence technology is helping diagnose the U.S.’s most deadly cancer sooner, greatly improving the ...
This summer, 75-year-old Antioch Township Treasurer and Mesick resident Kathy Soerries was preparing for a family vacation to ...
Humphrey traveled from Michigan to Chicago to seek a second opinion at Northwestern Medicine in May 2024. A bronchoscopy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback